MS in computer science, human-computer interaction, electrical engineering, bioinformatics, robotics or related field. 5+ years experience developing in C/C++.
From Facebook - Tue, 28 Jul 2020 06:16:57 GMT - View all Redmond, WA jobs

Adapts bioinformatics tools, visualization packages, and annotation resources for research projects to independently and accurately perform research analysis –…
From Medical College of Wisconsin - Tue, 28 Jul 2020 03:09:43 GMT - View all Milwaukee, WI jobs

Funding Opportunity RFA-AG-21-029 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications that apply a cross-disciplinary and team science approach to gain comprehensive mechanistic understanding of the impact of sex differences on the trajectories of brain aging, phenotypes, and risk of Alzheimer's Disease (AD) and AD-related dementia (ADRD), and on precision medicine for treatment and prevention of AD/ADRD, including the responsiveness to pharmacologic and non-pharmacologic interventions.

Funding Opportunity PAR-20-279 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to accelerate the development of devices to treat Substance Use Disorders (SUDs). The continuing advances in technologies offer unprecedented opportunities to develop neuromodulatory or neurophysiological devices that are safe and effective SUD treatments. The objective is to move devices to their next step in the FDA approval process, with the ultimate goal of generating new, FDA approved device-based treatments for SUDs.

Notice NOT-CA-20-092 from the NIH Guide for Grants and Contracts

Notice NOT-DA-20-072 from the NIH Guide for Grants and Contracts

Competitive + Benefits: Heptares Therapeutics Limited: Sosei Heptares (the corporate brand of Sosei Group Corporation) is a research-focused biotechnology group Cambridge, Cambridgeshire

The Role and opportunity Are you a Senior Scientist looking to make an impact and shape the direction of research within an innovative internationally recognised

Notice NOT-AG-20-044 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-OH-21-003 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to extend and expand the World Trade Center Health Registry developed and managed by the New York City Department of Health and Mental Hygiene in a cooperative agreement with CDC. The new project will ensure ongoing data collection for victims of the September 11, 2001, terrorist attacks on the World Trade Center (WTC). The registry will continue to provide a central, unified database to assess short-term and long-term health effects among persons exposed to the WTC disaster.

Notice NOT-HL-20-805 from the NIH Guide for Grants and Contracts

Notice NOT-HL-20-804 from the NIH Guide for Grants and Contracts

Notice NOT-HL-20-803 from the NIH Guide for Grants and Contracts

Notice NOT-HL-20-801 from the NIH Guide for Grants and Contracts

Notice NOT-HL-20-800 from the NIH Guide for Grants and Contracts

Notice NOT-HL-20-799 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-DK-20-019 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications for a Scientific Data Coordinating Center (SDCC) to support and provide scientific guidance as part of the new consortium to study Chronic Kidney Disease of UnceRtain Etiology (CKDu) in Agricultural Communities (CURE). The SDCC will guide the consortium as it develops protocols for epidemiologic studies. It will provide data management and analysis, as well as overall project management for the consortium. This collaborative research consortium will bring together a broad range of expertise and enable discovery science to understand the cause or causes of CKDu and disease progression. The consortium will also work to identify potential therapeutic targets and public health interventions. The consortium will consist of a Scientific Data Coordinating Center, Field Sites, a Renal Analytic Core and the NIEHS Human Health Exposure Analysis Resource (HHEAR). The consortium will work together to develop common protocols for evaluation of participants who are currently affected with early manifestations of CKDu and control participants, to define common strategies for biological sampling and environmental assessment, and to determine analytic strategies to best use the samples collected by the consortium. This FOA will not support intervention trials to prevent or treat CKDu. This FOA is intended to support only human studies and applications that include animal or model systems are not responsive.

Funding Opportunity RFA-DK-20-018 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications for a Renal Science Core to support and provide scientific guidance as part of the new consortium to study Chronic Kidney Disease of UnceRtain Etiology (CKDu) in Agricultural Communities (CURE). The Renal Analytic Core (RAC) will provide leadership in discovery science and support the analytic needs of the new consortium. The RAC will assess renal function, analyze kidney biopsies, devise and carry out a scientific approach to understanding the cause or causes of CKDu, including planning a biological sampling strategy to be implemented at Field Sites. This collaborative research consortium will bring together a broad range of expertise and enable discovery science to understand the cause or causes of CKDu and disease progression. The consortium will also work to identify potential therapeutic targets and public health interventions. The consortium will consist of a Scientific Data Coordinating Center, Field Sites, a Renal Analytic Core and the NIEHS Human Health Exposure Analysis Resource (HHEAR). The consortium will work together to develop common protocols for evaluation of participants who are currently affected with early manifestations of CKDu and control participants, to define common strategies for biosampling and environmental assessment, and to determine analytic strategies to best use the samples collected by the consortium. This FOA will not support intervention trials to prevent or treat CKDu. This FOA is intended to support only human studies and applications that include animal or model systems are not responsive.

Funding Opportunity RFA-DK-20-017 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications for Field Sites to enroll research participants in the consortium to study Chronic Kidney Disease of UnceRtain Etiology (CKDu) in Agricultural Communities (CURE). The Field Sites will identify, recruit and study participants with evidence of CKDu and appropriate controls, and collect biological and environmental samples. This collaborative research consortium will bring together a broad range of expertise and enable discovery science to understand the cause or causes of CKDu and disease progression. The consortium will also work to identify potential therapeutic targets and public health interventions. The consortium will consist of a Scientific Data Coordinating Center, Field Sites, a Renal Analytic Core and the NIEHS Human Health Exposure Analysis Resource (HHEAR). The consortium will work together to develop common protocols for evaluation of participants who are currently affected with early manifestations of CKDu and control participants, to define common strategies for biological sampling and environmental assessment, and to determine analytic strategies to best use the samples collected by the consortium. This FOA will not support intervention trials to prevent or treat CKDu. This FOA is intended to support only human studies and applications that include animal or model systems are not responsive.

Notice NOT-CA-20-086 from the NIH Guide for Grants and Contracts